Richard Arebelo is a seasoned professional with over 13 years of experience in the pharmaceutical industry, currently serving as the Senior Manager of Data Management at Amgen. In this pivotal role, Richard oversees Clinical Data Management (CDM) activities within the biosimilars operational unit, where he...
Richard Arebelo is a seasoned professional with over 13 years of experience in the pharmaceutical industry, currently serving as the Senior Manager of Data Management at Amgen. In this pivotal role, Richard oversees Clinical Data Management (CDM) activities within the biosimilars operational unit, where he collaborates closely with a Contract Research Organization (CRO) in a fully outsourced business model. His expertise in Electronic Data Capture (EDC) systems, including Medidata Rave, Oracle, and Bioclinica, positions him as a key player in ensuring the integrity and timeliness of study data delivery.
Richard is instrumental in leading the CDM function and managing system integrations between Amgen and various external partners. His proficiency in various Interactive Response Technology (IRT) vendor integrations, such as Bracket and ERT, enables seamless data flow and enhances operational efficiency across projects. He is adept at utilizing advanced data analytics tools like Spotfire and J-review, which facilitate informed decision-making and regulatory compliance.
As a people leader, Richard excels in fostering a collaborative environment that encourages innovation and problem-solving. His strong communication skills and supervisory capabilities have made him an overachiever in his field, driving successful project outcomes and enhancing patient safety. Richard’s commitment to excellence in data management not only supports Amgen’s strategic goals but also contributes to the advancement of biosimilar therapies, ultimately benefiting patients worldwide. His comprehensive knowledge of regulatory affairs and data management processes underscores his role as a vital asset to the organization and the broader pharmaceutical landscape.
